Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple genetic and treatment pathways, with over 20 identified genes and four ...

Read a review that discusses the pathogenesis and classification, clinical manifestations, diagnostic assessment, prognosis, and therapeutic strategies associated with pulmonary hypertension.

Merck said that a phase-three study of its pulmonary arterial hypertension treatment met its primary endpoints.

Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension.

Overall Count and Share for 'Unit Pulmonary Hypertension: Pathophysiology and Novel Therapies' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Pathophysiology refers to the effects on the body that a condition can cause. ... Pulmonary hypertension refers to high blood pressure of the arteries in the lungs and the right side of the heart.

Merck's drug boosts exercise capacity in pulmonary hypertension patients. By Khushi Mandowara. March 6, 2023 8:40 PM UTC Updated March 6, 2023 The Merck logo is seen at a gate to ...

Charles Burger, MD: Pulmonary hypertension really refers to a state where the right heart is generating high pressures to circulate the blood through the lung. Pulmonary arterial hypertension is a ...

The pulmonary vasculature is the exclusive target of disease in PPH, although its pathogenesis remains speculative. The most widely accepted mechanism suggests that PPH is a disease of predisposed ...